InMed Pharmaceuticals, Inc. (INM)
1.305
+0.02
(+1.16%)
USD |
NASDAQ |
Sep 14, 16:00
1.305
0.00 (0.00%)
After-Hours: 17:01
InMed Pharmaceuticals Price to Book Value : 6.482 for Sept. 14, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| September 11, 2026 | 6.407 |
| September 10, 2026 | 6.507 |
| September 09, 2026 | 6.507 |
| September 08, 2026 | 6.606 |
| September 04, 2026 | 6.854 |
| September 03, 2026 | 6.606 |
| September 02, 2026 | 6.705 |
| September 01, 2026 | 6.556 |
| August 31, 2026 | 6.705 |
| August 28, 2026 | 6.854 |
| August 27, 2026 | 7.103 |
| August 26, 2026 | 7.103 |
| August 25, 2026 | 7.152 |
| August 24, 2026 | 7.103 |
| August 21, 2026 | 7.252 |
| August 20, 2026 | 7.848 |
| August 19, 2026 | 7.897 |
| August 18, 2026 | 7.152 |
| August 17, 2026 | 7.252 |
| August 14, 2026 | 7.301 |
| August 13, 2026 | 7.103 |
| August 12, 2026 | 7.152 |
| August 11, 2026 | 7.252 |
| August 10, 2026 | 7.003 |
| August 07, 2026 | 7.301 |
| Date | Value |
|---|---|
| August 06, 2026 | 7.103 |
| August 05, 2026 | 6.954 |
| August 04, 2026 | 7.401 |
| August 03, 2026 | 7.252 |
| July 31, 2026 | 7.301 |
| July 30, 2026 | 7.450 |
| July 29, 2026 | 8.295 |
| July 28, 2026 | 8.295 |
| July 27, 2026 | 8.146 |
| July 24, 2026 | 8.493 |
| July 23, 2026 | 9.189 |
| July 22, 2026 | 8.245 |
| July 21, 2026 | 7.649 |
| July 20, 2026 | 7.550 |
| July 17, 2026 | 7.550 |
| July 16, 2026 | 7.897 |
| July 15, 2026 | 7.897 |
| July 14, 2026 | 7.748 |
| July 13, 2026 | 7.798 |
| July 10, 2026 | 8.146 |
| July 09, 2026 | 8.245 |
| July 08, 2026 | 8.195 |
| July 07, 2026 | 8.295 |
| July 06, 2026 | 7.997 |
| July 02, 2026 | 7.748 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| NervGen Pharma Corp. | 19.14 |
| Milestone Pharmaceuticals, Inc. | 6.496 |
| Clearmind Medicine, Inc. | 0.1524 |
| Lexaria Bioscience Corp. | 1.224 |
| Target Group, Inc. (Canada) | -- |
Price to Book Value Related Metrics
| PS Ratio | 2.746 |
| Price | 1.305 |
| Earnings Yield | -238.8% |
| Market Cap | 6.968M |